Categories AlphaGraphs, Consumer, Earnings, Health Care
Johnson & Johnson (JNJ) reports Q3 2021 earnings
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday.
The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational growth of 9.9%
Net earnings of $3.6 billion or $1.37 per share increased by 3%, also topped the target that analysts had anticipated.
Most Popular
Should investors worry about Micron’s (MU) weak Q4 results and guidance?
The semiconductor industry is a rapidly growing business segment that currently thrives on the digital transformation wave. The demand for memory chips and other semiconductor products increased over the years,
What has Bed Bath & Beyond (BBBY) outlined for this fiscal year?
Shares of Bed Bath & Beyond (NASDAQ: BBBY) were up on Friday, a day after the company delivered disappointing results for the second quarter of 2022. The company reported a
NKE Earnings: Highlights of Nike’s Q1 2023 results
Nike, Inc. (NYSE: NKE) has reported a decrease in net profit for the first quarter of 2023, despite a modest increase in revenues. The company's stock suffered a big loss
